| 57 | Humans |
| 39 | Indium Radioisotopes (diagnostic use) |
| 36 | Male |
| 32 | Female |
| 30 | Animals |
| 24 | Middle Aged |
| 22 | Adult |
| 19 | Aged |
| 12 | Dogs |
| 12 | Antibodies, Monoclonal (diagnostic use) |
| 9 | Indium (diagnostic use) |
| 8 | Radioisotopes (diagnostic use) |
| 7 | Rats |
| 7 | Mice |
| 7 | Indium (chemistry) |
| 6 | Tissue Distribution |
| 6 | Time Factors |
| 6 | Radiopharmaceuticals (diagnostic use) |
| 6 | Radionuclide Imaging |
| 6 | Radioisotopes |
| 6 | Oxyquinoline (diagnostic use) |
| 6 | Oxyquinoline (analogs & derivatives) |
| 6 | Organometallic Compounds (diagnostic use) |
| 5 | Pentetic Acid (diagnostic use) |
| 5 | Microscopy, Electron, Scanning |
| 5 | Melanoma (radionuclide imaging) |
| 5 | Leukocytes |
| 5 | Indium |
| 5 | Indium Radioisotopes |
| 5 | Cells, Cultured |
| 5 | Blood Vessel Prosthesis |
| 5 | Aged, 80 and over |
| 4 | Technetium (diagnostic use) |
| 4 | Surface Properties |
| 4 | Polytetrafluoroethylene |
| 4 | Pentetic Acid (analogs & derivatives) |
| 4 | Neoplasm Recurrence, Local (radionuclide imaging) |
| 4 | Magnetic Resonance Imaging |
| 4 | Indium Radioisotopes (pharmacokinetics) |
| 4 | Indium (pharmacology) |
| 4 | Endothelium, Vascular (cytology) |
| 4 | Colorectal Neoplasms (radionuclide imaging) |
| 4 | Cell Survival |
| 4 | Antibodies, Monoclonal (metabolism) |
| 3 | Tropolone (diagnostic use) |
| 3 | Stress, Mechanical |
| 3 | Stem Cell Transplantation |
| 3 | Sensitivity and Specificity |
| 3 | Retrospective Studies |
| 3 | Rats, Inbred Strains |
| 3 | Prospective Studies |
| 3 | Pregnancy |
| 3 | Octreotide (diagnostic use) |
| 3 | Mice, Nude |
| 3 | Melanoma (secondary) |
| 3 | Materials Testing |
| 3 | Liver (drug effects) |
| 3 | Lasers |
| 3 | Heparin (pharmacology) |
| 3 | Gallium Radioisotopes (diagnostic use) |
| 3 | Gallium (chemistry) |
| 3 | Follow-Up Studies |
| 3 | Endothelium, Vascular (physiology) |
| 3 | Electrodes |
| 3 | Colon (radionuclide imaging) |
| 3 | Cell Movement |
| 3 | Brain Neoplasms (radionuclide imaging) |
| 3 | Antigens, Neoplasm (immunology) |
| 2 | Vascular Patency |
| 2 | Tumor Markers, Biological (metabolism) |
| 2 | Treatment Outcome |
| 2 | Transplantation, Heterologous |
| 2 | Tomography, X-Ray Computed |
| 2 | Tin Compounds (chemistry) |
| 2 | Technetium |
| 2 | Somatostatin (diagnostic use) |
| 2 | Somatostatin (analogs & derivatives) |
| 2 | Serine (analogs & derivatives) |
| 2 | Semiconductors |
| 2 | Scandium (pharmacology) |
| 2 | Reproducibility of Results |
| 2 | Radionuclide Imaging (methods) |
| 2 | Radioimmunodetection |
| 2 | Rabbits |
| 2 | Protein Binding |
| 2 | Prosthesis-Related Infections (radionuclide imaging) |
| 2 | Prognosis |
| 2 | Polystyrenes (chemistry) |
| 2 | Platelet Adhesiveness (drug effects) |
| 2 | Placenta |
| 2 | Peptides (chemistry) |
| 2 | Pentetic Acid |
| 2 | Pentetic Acid (pharmacokinetics) |
| 2 | Pentetic Acid (chemistry) |
| 2 | Particle Size |
| 2 | Osteomyelitis (radionuclide imaging) |
| 2 | Organotechnetium Compounds (diagnostic use) |
| 2 | Organometallic Compounds |
| 2 | Organometallic Compounds (pharmacokinetics) |
| 2 | Organometallic Compounds (chemistry) |
| 2 | Organometallic Compounds (chemical synthesis) |
| 2 | Oligopeptides (diagnostic use) |
| 2 | Octreotide (analogs & derivatives) |
| 2 | Neoplasm Transplantation |
| 2 | Myocardial Infarction (radionuclide imaging) |
| 2 | Molecular Structure |
| 2 | Models, Molecular |
| 2 | Models, Biological |
| 2 | Mitochondria, Liver (metabolism) |
| 2 | Microscopy, Electron |
| 2 | Metal Nanoparticles (chemistry) |
| 2 | Melanoma (immunology) |
| 2 | Mass Spectrometry |
| 2 | Lung Neoplasms (radionuclide imaging) |
| 2 | Liver Neoplasms (secondary) |
| 2 | Liver Neoplasms (radionuclide imaging) |
| 2 | Liver (enzymology) |
| 2 | Leukocytes (radionuclide imaging) |
| 2 | Ions |
| 2 | Indium Radioisotopes (metabolism) |
| 2 | Indium Radioisotopes (analysis) |
| 2 | Indium (toxicity) |
| 2 | Indium (metabolism) |
| 2 | Immunotherapy |
| 2 | Immunoglobulin Fab Fragments (diagnostic use) |
| 2 | Immunization, Passive |
| 2 | Immune Tolerance |
| 2 | Granulocytes (immunology) |
| 2 | Glioma (radionuclide imaging) |
| 2 | Fibroblast Growth Factor 1 (pharmacology) |
| 2 | Evaluation Studies as Topic |
| 2 | Enterobactin (pharmacology) |
| 2 | Energy Transfer |
| 2 | Endothelium, Vascular (ultrastructure) |
| 2 | Dihematoporphyrin Ether (pharmacokinetics) |
| 2 | Diagnosis, Differential |
| 2 | Cross-Sectional Studies |
| 2 | Chelating Agents |
| 2 | Cell Adhesion |
| 2 | Carcinoid Tumor (radionuclide imaging) |
| 2 | Breast Neoplasms (radionuclide imaging) |
| 2 | Brain Neoplasms (drug therapy) |
| 2 | Brain (drug effects) |
| 2 | Blood Platelets (ultrastructure) |
| 2 | Biopsy |
| 2 | Arsenicals (chemistry) |
| 2 | Antibodies, Monoclonal (therapeutic use) |
| 2 | Adsorption |
| 1 | Zymosan (pharmacology) |
| 1 | Zinc Sulfate |
| 1 | Zinc (pharmacology) |
| 1 | X-Rays |
| 1 | Wood (chemistry) |
| 1 | Wegener Granulomatosis (therapy) |
| 1 | Wegener Granulomatosis (radionuclide imaging) |
| 1 | Wegener Granulomatosis (diagnosis) |
| 1 | Vibration |
| 1 | Vasodilation (physiology) |
| 1 | Vasoconstriction (physiology) |
| 1 | Vasculitis, Leukocytoclastic, Cutaneous (therapy) |
| 1 | Vasculitis, Leukocytoclastic, Cutaneous (pathology) |
| 1 | Vasculitis, Leukocytoclastic, Cutaneous (immunology) |
| 1 | Vasculitis (drug therapy) |
| 1 | Vasculitis (diagnosis) |
| 1 | Vacuum |
| 1 | Umbilical Veins (cytology) |
| 1 | Ultrasonography |
| 1 | Ultrasonography (methods) |
| 1 | Tumor Necrosis Factor-alpha (physiology) |
| 1 | Tumor Necrosis Factor-alpha (immunology) |
| 1 | Tumor Cells, Cultured |
| 1 | Tryptophan (chemistry) |
| 1 | Tropolone (toxicity) |
| 1 | Tropolone (pharmacokinetics) |
| 1 | Tropolone (analogs & derivatives) |
| 1 | Transferrin |
| 1 | Tomography, Emission-Computed, Single-Photon |
| 1 | Tomography, Emission-Computed, Single-Photon (methods) |
| 1 | Tomography, Emission-Computed, Single-Photon (instrumentation) |
| 1 | Titanium (chemistry) |
| 1 | Tissue Scaffolds |
| 1 | Tissue Engineering (methods) |
| 1 | Time |
| 1 | Thyroid Neoplasms (surgery) |
| 1 | Thyroid Neoplasms (radionuclide imaging) |
| 1 | Thyroid Neoplasms (pathology) |
| 1 | Thyroid Gland (radionuclide imaging) |
| 1 | Thyroid Gland (pathology) |
| 1 | Thymus Neoplasms (radionuclide imaging) |
| 1 | Thrombosis (radionuclide imaging) |
| 1 | Thrombosis (prevention & control) |
| 1 | Thrombosis (blood) |
| 1 | Temperature |
| 1 | Technetium Tc 99m Sulfur Colloid (diagnostic use) |
| 1 | Technetium Tc 99m Medronate (diagnostic use) |
| 1 | Technetium Tc 99m Exametazime |
| 1 | Technetium Tc 99m Exametazime (diagnostic use) |
| 1 | Technetium Tc 99m Disofenin |
| 1 | Technetium Compounds (diagnostic use) |
| 1 | Tablets |
| 1 | Synovitis (physiopathology) |
| 1 | Synaptic Membranes (drug effects) |
| 1 | Symporters (genetics) |
| 1 | Sympathetic Nervous System (physiology) |
| 1 | Sympathetic Nervous System (drug effects) |
| 1 | Swine |
| 1 | Sulfides (chemistry) |
| 1 | Sulfates (pharmacology) |
| 1 | Sugar Acids (diagnostic use) |
| 1 | Subtraction Technique |
| 1 | Substrate Specificity |
| 1 | Structure-Activity Relationship |
| 1 | Stomach Neoplasms (radionuclide imaging) |
| 1 | Stomach Neoplasms (metabolism) |
| 1 | Stomach (physiology) |
| 1 | Steroids |
| 1 | Stereotaxic Techniques |
| 1 | Stem Cells (radionuclide imaging) |
| 1 | Stem Cells (physiology) |
| 1 | Stem Cells (cytology) |
| 1 | Static Electricity |
| 1 | Staining and Labeling (methods) |
| 1 | Splenic Diseases (diagnosis) |
| 1 | Spleen (radionuclide imaging) |
| 1 | Spleen (physiopathology) |
| 1 | Spleen (cytology) |
| 1 | Spinal Cord Injuries (radionuclide imaging) |
| 1 | Spinal Cord Injuries (physiopathology) |
| 1 | Spinal Cord Injuries (complications) |
| 1 | Spectrum Analysis, Raman (methods) |
| 1 | Spectrophotometry, Ultraviolet |
| 1 | Species Specificity |
| 1 | Solubility |
| 1 | Skull Neoplasms (secondary) |
| 1 | Skull Neoplasms (radionuclide imaging) |
| 1 | Skin Ulcer (therapy) |
| 1 | Skin Ulcer (immunology) |
| 1 | Skin Neoplasms (pathology) |
| 1 | Skin (pathology) |
| 1 | Skin (blood supply) |
| 1 | Sjogren's Syndrome (therapy) |
| 1 | Silicon Dioxide (chemistry) |
| 1 | Silicon (chemistry) |
| 1 | Signal-To-Noise Ratio |
| 1 | Sigmoidoscopy |
| 1 | Shear Strength |
| 1 | Serum Albumin |
| 1 | Serine Endopeptidases (metabolism) |
| 1 | Serine Endopeptidases (immunology) |
| 1 | Scattering, Radiation |
| 1 | Samarium |
| 1 | Salvage Therapy |
| 1 | Salts (chemistry) |
| 1 | Salicylic Acid |
| 1 | Salicylates (analysis) |
| 1 | Rotation |
| 1 | Risk Factors |
| 1 | Ricin (administration & dosage) |
| 1 | Rhizophoraceae (chemistry) |
| 1 | Rheology |
| 1 | Respiration (drug effects) |
| 1 | Resins, Synthetic (diagnostic use) |
| 1 | Regional Blood Flow (drug effects) |
| 1 | Recurrence |
| 1 | Rectal Neoplasms (therapy) |
| 1 | Receptors, Somatostatin (analysis) |
| 1 | Receptors, Interleukin-2 (analysis) |
| 1 | Receptor, Epidermal Growth Factor (immunology) |
| 1 | Rats, Sprague-Dawley |
| 1 | Rats, Inbred WKY |
| 1 | Rats, Inbred Lew |
| 1 | Radiotherapy Dosage |
| 1 | Radiopharmaceuticals (pharmacokinetics) |
| 1 | Radiopharmaceuticals (chemistry) |
| 1 | Radiometry (methods) |
| 1 | Radioisotopes (adverse effects) |
| 1 | Radioisotopes (administration & dosage) |
| 1 | Radioimmunotherapy |
| 1 | Radioimmunoassay |
| 1 | Radiation Effects |
| 1 | Radiation Dosage |
| 1 | Quinoxalines (pharmacokinetics) |
| 1 | Quinoxalines (chemistry) |
| 1 | Quinoxalines (chemical synthesis) |
| 1 | Quantum Dots |
| 1 | Quality-Adjusted Life Years |
| 1 | Quality Control |
| 1 | Purpura, Thrombocytopenic, Idiopathic (radionuclide imaging) |
| 1 | Purpura, Thrombocytopenic, Idiopathic (physiopathology) |
| 1 | Pulmonary Alveoli (immunology) |
| 1 | Puerperal Disorders (radionuclide imaging) |
| 1 | Proteinase Inhibitory Proteins, Secretory (metabolism) |
| 1 | Prosthesis-Related Infections (epidemiology) |
| 1 | Prostatic Neoplasms (surgery) |
| 1 | Prostatic Neoplasms (radiotherapy) |
| 1 | Prostatic Neoplasms (radionuclide imaging) |
| 1 | Prostatic Neoplasms (blood) |
| 1 | Prostatectomy |
| 1 | Prostate-Specific Antigen (blood) |
| 1 | Proctocolectomy, Restorative (adverse effects) |
| 1 | Probenecid (pharmacokinetics) |
| 1 | Potassium Chloride (pharmacology) |
| 1 | Posture |
| 1 | Postoperative Complications (radionuclide imaging) |
| 1 | Postoperative Complications (blood) |
| 1 | Positron-Emission Tomography |
| 1 | Porphyrins (chemistry) |
| 1 | Porphobilinogen Synthase (antagonists & inhibitors) |
| 1 | Porosity |
| 1 | Polytetrafluoroethylene (pharmacology) |
| 1 | Polymethacrylic Acids |
| 1 | Polylysine (chemistry) |
| 1 | Polyesters |
| 1 | Pneumonia (immunology) |
| 1 | Platinum (chemistry) |
| 1 | Platelet Aggregation |
| 1 | Platelet Aggregation (physiology) |
| 1 | Platelet Aggregation (drug effects) |
| 1 | Platelet Adhesiveness (physiology) |
| 1 | Placenta Previa (diagnosis) |
| 1 | Physicochemical Phenomena |
| 1 | Phototherapy |
| 1 | Photosensitizing Agents (toxicity) |
| 1 | Photosensitizing Agents (therapeutic use) |
| 1 | Photochemotherapy |
| 1 | Photochemistry (instrumentation) |
| 1 | Phospholipids (metabolism) |
| 1 | Phenylephrine (pharmacology) |
| 1 | Phantoms, Imaging |
| 1 | Peritoneal Neoplasms (therapy) |
| 1 | Peritoneal Neoplasms (secondary) |
| 1 | Peritoneal Neoplasms (radionuclide imaging) |
| 1 | Peptides (pharmacokinetics) |
| 1 | Peptides (diagnostic use) |
| 1 | Pentetic Acid (metabolism) |
| 1 | Pentetic Acid (chemical synthesis) |
| 1 | Pelvic Bones (radionuclide imaging) |
| 1 | Pancreatic Neoplasms (pathology) |
| 1 | Pancreatic Neoplasms (metabolism) |
| 1 | Palladium (chemistry) |
| 1 | Oxyquinoline (toxicity) |
| 1 | Oxygenases (metabolism) |
| 1 | Oxygen Consumption (drug effects) |
| 1 | Oxygen (analysis) |
| 1 | Oxo-Acid-Lyases (metabolism) |
| 1 | Oxo-Acid-Lyases (genetics) |
| 1 | Oximes (diagnostic use) |
| 1 | Oxidoreductases (metabolism) |
| 1 | Oxidation-Reduction |
| 1 | Ovarian Neoplasms (radiotherapy) |
| 1 | Osteomyelitis (diagnosis) |
| 1 | Osteolysis (radionuclide imaging) |
| 1 | Osteitis Deformans (radionuclide imaging) |
| 1 | Optics and Photonics (instrumentation) |
| 1 | Optical Imaging (methods) |
| 1 | Ophthalmology (methods) |
| 1 | Oligopeptides (pharmacokinetics) |
| 1 | Nitroglycerin (pharmacology) |
| 1 | Nitrogen (diagnostic use) |
| 1 | Nitrilotriacetic Acid |
| 1 | Neutrophils (drug effects) |
| 1 | Neuroendocrine Tumors (radionuclide imaging) |
| 1 | Neuroendocrine Tumors (radiography) |
| 1 | Neuroendocrine Tumors (pathology) |
| 1 | Neuroblastoma (secondary) |
| 1 | Neuroblastoma (radionuclide imaging) |
| 1 | Neuraminidase (antagonists & inhibitors) |
| 1 | Neoplasms (metabolism) |
| 1 | Neoplasm Staging |
| 1 | Neoplasm Recurrence, Local (radiotherapy) |
| 1 | Neoplasm Recurrence, Local (radiography) |
| 1 | Neoplasm Recurrence, Local (pathology) |
| 1 | Neoplasm Recurrence, Local (drug therapy) |
| 1 | Neoplasm Recurrence, Local (blood) |
| 1 | Neoplasm Proteins (immunology) |
| 1 | Neoplasm Metastasis |
| 1 | Neck Dissection |
| 1 | Nanotubes, Carbon (chemistry) |
| 1 | Nanotechnology (methods) |
| 1 | Nanostructures (ultrastructure) |
| 1 | Nanostructures (chemistry) |
| 1 | Nanocapsules (chemistry) |
| 1 | N-Formylmethionine Leucyl-Phenylalanine (pharmacology) |
| 1 | Myocardial Perfusion Imaging (methods) |
| 1 | Myocardial Infarction (surgery) |
| 1 | Myocardial Infarction (pathology) |
| 1 | Mycobacterium tuberculosis (immunology) |
| 1 | Muscle, Smooth, Vascular (physiology) |
| 1 | Muscle Relaxation |
| 1 | Multiple Endocrine Neoplasia Type 1 (radionuclide imaging) |
| 1 | Mucin-1 |
| 1 | Monocytes (transplantation) |
| 1 | Monocytes (metabolism) |
| 1 | Monocytes (immunology) |
| 1 | Monocytes (cytology) |
| 1 | Molecular Weight |
| 1 | Molecular Sequence Data |
| 1 | Molecular Probes (chemistry) |
| 1 | Molecular Imaging (methods) |
| 1 | Models, Theoretical |
| 1 | Models, Econometric |
| 1 | Mixed Function Oxygenases (metabolism) |
| 1 | Mitochondria, Liver (drug effects) |
| 1 | Milk, Human (analysis) |
| 1 | Microsomes, Liver (ultrastructure) |
| 1 | Microsomes, Liver (metabolism) |
| 1 | Microsomes, Liver (enzymology) |
| 1 | Microsomes, Liver (drug effects) |
| 1 | Microfluidic Analytical Techniques (methods) |
| 1 | Microelectrodes |
| 1 | Microcirculation (drug effects) |
| 1 | Microbial Sensitivity Tests |
| 1 | Micelles |
| 1 | Metronidazole (therapeutic use) |
| 1 | Methods |
| 1 | Methane (chemistry) |
| 1 | Methane (analogs & derivatives) |
| 1 | Metals (pharmacology) |
| 1 | Metal Ceramic Alloys (chemistry) |
| 1 | Metabolic Clearance Rate |
| 1 | Metabolic Clearance Rate (physiology) |
| 1 | Meningioma (radionuclide imaging) |
| 1 | Meningioma (drug therapy) |
| 1 | Meninges (radionuclide imaging) |
| 1 | Meninges (pathology) |
| 1 | Membrane Potentials |
| 1 | Membrane Lipids (metabolism) |
| 1 | Membrane Glycoproteins (immunology) |
| 1 | Membrane Fluidity (drug effects) |
| 1 | Melanoma-Specific Antigens |
| 1 | Melanoma (pathology) |
| 1 | Medulla Oblongata (physiology) |
| 1 | Medulla Oblongata (drug effects) |
| 1 | Mammography (instrumentation) |
| 1 | Magnetic Resonance Spectroscopy |
| 1 | Magnetic Resonance Imaging (methods) |
| 1 | Macrophages (cytology) |
| 1 | Lysosomes (enzymology) |
| 1 | Lysosomes (drug effects) |
| 1 | Lymphoid Tissue (cytology) |
| 1 | Lymphocytes, Tumor-Infiltrating (radionuclide imaging) |
| 1 | Lymphocytes (physiology) |
| 1 | Lymphocytes (immunology) |
| 1 | Lymphocytes (cytology) |
| 1 | Lymphocyte Activation |
| 1 | Lymphatic Metastasis |
| 1 | Lymph Nodes (radionuclide imaging) |
| 1 | Lymph Nodes (pathology) |
| 1 | Lymph Nodes (cytology) |
| 1 | Lung Neoplasms (secondary) |
| 1 | Lung Neoplasms (drug therapy) |
| 1 | Luminescent Measurements |
| 1 | Lumbar Vertebrae (radionuclide imaging) |
| 1 | Liver Neoplasms (pathology) |
| 1 | Liver Diseases (diagnosis) |
| 1 | Liver (radionuclide imaging) |
| 1 | Liver (physiopathology) |
| 1 | Liver (metabolism) |
| 1 | Liver (analysis) |
| 1 | Liposomes (diagnostic use) |
| 1 | Light |
| 1 | Ligands |
| 1 | Leukotriene B4 (pharmacology) |
| 1 | Leukocytes, Mononuclear (pathology) |
| 1 | Leukocytes, Mononuclear (metabolism) |
| 1 | Leukocytes, Mononuclear (immunology) |
| 1 | Leukocytes (pathology) |
| 1 | Leg (blood supply) |
| 1 | Lectins |
| 1 | Lead (pharmacology) |
| 1 | Knee Prosthesis (adverse effects) |
| 1 | Knee Joint (immunology) |
| 1 | Klebsiella pneumoniae (drug effects) |
| 1 | Klebsiella Infections (drug therapy) |
| 1 | Kinetics |
| 1 | Killer Cells, Natural (transplantation) |
| 1 | Killer Cells, Natural (immunology) |
| 1 | Killer Cells, Natural (cytology) |
| 1 | Kidney Tubules, Proximal (ultrastructure) |
| 1 | Kidney Tubules, Proximal (drug effects) |
| 1 | Kidney (ultrastructure) |
| 1 | Kidney (radionuclide imaging) |
| 1 | Kidney (physiopathology) |
| 1 | Kidney (innervation) |
| 1 | Kidney (enzymology) |
| 1 | Kidney (drug effects) |
| 1 | Jugular Veins |
| 1 | Isotope Labeling |
| 1 | Islets of Langerhans (metabolism) |
| 1 | Islets of Langerhans (cytology) |
| 1 | Ischemia (therapy) |
| 1 | Ischemia (radionuclide imaging) |
| 1 | Ischemia (blood) |
| 1 | Iron (metabolism) |
| 1 | Iodine Radioisotopes (metabolism) |
| 1 | Iodine Isotopes |
| 1 | Intestinal Mucosa (pathology) |
| 1 | Intervertebral Disc Displacement (radionuclide imaging) |
| 1 | Intervertebral Disc Displacement (diagnosis) |
| 1 | Interleukin-2 (pharmacokinetics) |
